SCHEMBL3662077

SCHEMBL3662077

CCCCCCCCCCC(=O)c1ccc(O)cc1O

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.97
KDM4E B2RXH2 1/20 0.69
HSP90AB1 P08238 1/20 0.64
LMNA P02545 2/20 0.60
HPGD P15428 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
ALDH1A1 P00352 2/20 0.60
HSD17B3 P37058 6/20 0.60
MEN1 O00255 2/20 0.54
MAPT P10636 2/20 0.54
KMT2A Q03164 2/20 0.54
FFAR1 O14842 1/20 0.54
PLA2G2A P14555 1/20 0.54
PLA2G5 P39877 1/20 0.54
ATM Q13315 1/20 0.54
TP53 P04637 1/20 0.51
CYP3A4 P08684 1/20 0.51
ALOX5 P09917 1/20 0.51
TYR P14679 1/20 0.51
ALOX15 P16050 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3656095 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL10350998 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL3659193 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL3655550 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL3660476 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL3660585 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL3654494 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL3659335 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL3656872 1.00 HTT (0.97) HTTKDM4EHSP90AB1LMNAHPGD
SCHEMBL1606859 0.98 HTT (1.00) HTTKDM4EHSP90AB1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC HTT 22/4885KDM4E 2821/4885HSP90AB1 1489/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR HTT 2960/4885KDM4E 1101/4885HSP90AB1 4254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.